Prediction of Patients Who Can Benefit from Oral Intestinal Sorbent AST-120

Lignende værker

• A Randomized, Controlled Trial of Oral Intestinal Sorbent AST-120 on Renal Function Deterioration in Patients with Advanced Renal Dysfunction
  af: Cha, Ran-hui, et al.
  Udgivet: (2016)
• Renal artery revascularisation: can we predict who benefits?
  af: Deoker, Abhizith, et al.
  Udgivet: (2017)
• Oral activated charcoal adsorbent (AST-120) ameliorates CKD-induced intestinal epithelial barrier disruption
  af: Vaziri, Nosratola D., et al.
  Udgivet: (2013)
• Oral Adsorbent AST–120 Decreases Serum Levels of AGEs in Patients with Chronic Renal Failure
  af: Ueda, Seiji, et al.
  Udgivet: (2006)
• Effect of an Oral Adsorbent, AST-120, on Dialysis Initiation and Survival in Patients with Chronic Kidney Disease
  af: Hatakeyama, Shingo, et al.
  Udgivet: (2012)